Skip to content
Review Open access

T-cell metabolic reprogramming in systemic lupus erythematosus: linking intracellular metabolism to effector differentiation and senescent-like/exhausted-like states

Oct 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 86 references
Medicine

TL;DR

This review summarizes recent advances in T-cell metabolic reprogramming in SLE and its potential relationship to senescent-like and exhausted-like T-cell states.

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune dysregulation and multiorgan inflammation. T-cell metabolic reprogramming has recently emerged as an active area of investigation in the pathogenesis of SLE. This metabolic reprogramming, which involves glycolysis, mitochondrial oxidative phosphorylation, glutamine metabolism, and lipid metabolism, is associated not only with functional alterations in SLE T cells but also with changes in their differentiation and proliferation, potentially contributing to disease pathogenesis and progression. Moreover, metabolic alterations, including mitochondrial dysfunction and reactive oxygen species accumulation, in the context of persistent T-cell activation may contribute to phenotypic transitions toward senescent-like or exhausted-like states. These two partially overlapping but biologically distinct cellular phenotypes may represent divergent cellular responses to chronic inflammatory stimulation. Rather than representing mutually exclusive states or a simple loss of function, both may contribute to the perpetuation of chronic inflammation, immune imbalance and disease activity. This review summarizes recent advances in T-cell metabolic reprogramming in SLE and its potential relationship to senescent-like and exhausted-like T-cell states.

Read PDF

Similar papers

Review Oct 2026

T-cell dysregulation in systemic lupus erythematosus: a four-layered model from extracellular cues to epigenetic remodeling and therapeutic opportunities.

The spectrum of T-cell abnormalities in SLE is synthesized and it is proposed that these phenotypes arise from four interacting layers of dysregulation: extracellular cues including cytokine and non-cytokine mediators and altered antigen presentation, T-cell receptor (TCR) and co-stimulatory signaling, immunometabolic...

Xiao-Yi Zheng, Hong-Rui Liu, Yong-Kang Chen et al. · 0 citations
Review Open access Oct 2026

Mitochondria-Macrophage Interactions in Sepsis at Different Immune Stages: Integrating Immunometabolic Reprogramming, Organ Damage, and Therapeutic Strategies

Abstract Sepsis is a life-threatening disorder caused by dysregulated host responses to infection, characterized by immune dysfunction, metabolic reprogramming, and multi-organ injury. Mitochondria, beyond their role in energy metabolism, act as central signaling hubs that integrate cellular metabolism, innate immunity...

Jia-Qi Li, Yu-Ting Sun, Mei-Lin He et al. · 0 citations
Review Open access Oct 2026

Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy

Immune checkpoint blockade (ICB) therapy has achieved clinical progress in various malignancies, yet primary and acquired resistance limits its efficacy in solid tumors. Myeloid cells in the tumor microenvironment (TME), including tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), and myeloid-der...

Ming-Xing Wang, Jian Chen, Zhong-Hua Wu et al. · 0 citations
Open access Oct 2026

Metabolic reprogramming of pathogenic CD4+ T helper cells attenuates inflammatory bowel disease in mice.

CD4+ effector T helper 1 (TH1) cells drive inflammatory bowel disease (IBD). Here, we investigated how integrated signaling, metabolic, and epigenetic programs sustain their pathogenic persistence. We found that enforcing mitochondrial pyruvate metabolism with methyl pyruvate (MePyr) suppressed TH1 cell effector functi...

Shravan K. Mishra, Leena M. Abdelrahman, Hyun Se Kim Lee et al. · 0 citations
Review Open access Sep 2026

Immunometabolism in health and disease: from cellular metabolic reprogramming to therapeutic opportunities

Cellular metabolism actively shapes immune cell fate, function, and lineage commitment through coordinated metabolic reprogramming, rather than serving merely as a passive energy supply. Distinct metabolic pathways, including glycolysis, mitochondrial respiration, fatty acid oxidation, and amino acid catabolism, govern...

Haksoo Shin · 0 citations
Review Open access Nov 2026

Immunometabolic and epigenetic reprogramming in inflammatory bowel disease: from mechanistic circuits to therapeutic targeting

Inflammatory bowel disease (IBD) is a chronic, immune-mediated disorder of the gastrointestinal tract and an escalating global public health challenge, particularly in newly industrializing regions. Its etiology and pathogenesis remain incompletely understood, although disrupted homeostasis between the intestinal micro...

Yi Han, Jun Yi, Xiao-Tong Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.